Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferences

Information for Patients

View all Images (122)

Other Resources UpToDate PubMed

Keratoacanthoma

See also in: External and Internal Eye,Hair and Scalp
Contributors: Jeffrey M. Cohen MD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

A keratoacanthoma is a rapidly growing, well-differentiated neoplasm of squamous epithelium. It assumes a distinct crater-shaped appearance and usually occurs as a solitary lesion on sun-exposed skin. It is considered by many to be a low-grade squamous cell carcinoma. Men are more commonly affected than women, individuals with lighter skin phototypes are at greater risk than those with darker skin phototypes, and peak incidence is between 65 and 71 years of age.

In contrast to squamous cell carcinomas, keratoacanthomas appear and grow rapidly over the course of a few weeks to a month. If left untreated, most keratoacanthomas spontaneously involute and resolve within 6 months, leaving an atrophic scar. It is thought that the immune system plays a role in spontaneous regression of keratoacanthomas.

Most keratoacanthomas are painless. Patients occasionally complain of pruritus within the lesion. They may cause mechanical or cosmetic deformity depending on the site of involvement. Most will cause only local destruction, but there are few that behave more aggressively. These are considered invasive variants. Metastases to draining lymph nodes, while seldom, have been reported.

Risk factors include ultraviolet (UV) light exposure and immunosuppression. Patients on immunosuppressants (eg, immunosuppression after solid organ transplantation) have increased numbers of more persistent and more chronic keratoacanthomas. Skin injury may also be a predisposing factor, as there are many reports of keratoacanthomas developing in sites of previous trauma, in surgical scars, after laser resurfacing, and following radiation therapy. Foreign bodies, such as tattoo ink, have also been identified as risk factors for keratoacanthomas.

While solitary typical keratoacanthomas are the most common presentation, there are also giant (2-15 cm in diameter), subungual, mucosal, and keratoacanthoma centrifugum marginatum (prominent horizontal growth pattern) variants.

In rare cases, multiple keratoacanthomas develop as part of a syndrome.
  • Ferguson-Smith syndrome is an autosomal dominant inherited disease characterized by multiple self-healing keratoacanthomas. Lesions occur within one localized area, such as on the face or trunk. Each lesion clinically resembles a solitary keratoacanthoma, and lesions scar with resolution.
  • In eruptive keratoacanthomas of Grzybowski, hundreds of lesions occur in a generalized distribution and may involve mucous membranes. Pruritus is a common feature, and lesions tend to heal without scarring.
  • Keratoacanthomas may occur within Muir-Torre syndrome along with sebaceous neoplasms and adenomatous colon carcinoma or other low-grade internal malignancies.
  • In familial keratoacanthomas of Witten and Zak, multiple larger and smaller keratoacanthomas are found.
Keratoacanthomas, including multiple eruptive keratoacanthomas, have been described in patients taking BRAF inhibitors such as vemurafenib and dabrafenib. Keratoacanthomas have also been associated with vismodegib and sorafenib use.

Codes

ICD10CM:
L85.8 – Other specified epidermal thickening

SNOMEDCT:
254662007 – Keratoacanthoma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Reviewed:02/09/2017
Last Updated:04/02/2017
Copyright © 2023 VisualDx®. All rights reserved.
Patient Information for Keratoacanthoma
Contributors: Medical staff writer
Premium Feature
VisualDx Patient Handouts
Available in the Elite package
  • Improve treatment compliance
  • Reduce after-hours questions
  • Increase patient engagement and satisfaction
  • Written in clear, easy-to-understand language. No confusing jargon.
  • Available in English and Spanish
  • Print out or email directly to your patient
Copyright © 2023 VisualDx®. All rights reserved.
Keratoacanthoma
See also in: External and Internal Eye,Hair and Scalp
A medical illustration showing key findings of Keratoacanthoma : Thick scaly papule, Warty
Clinical image of Keratoacanthoma - imageId=213569. Click to open in gallery.  caption: 'A close-up of a violaceous nodule with a central keratotic core.'
A close-up of a violaceous nodule with a central keratotic core.
Copyright © 2023 VisualDx®. All rights reserved.